Learn About Crispr Gene Editing ETF XDNA

Kelly Intel Founder & CEO Kevin Kelly joins Jill Malandrino on Nasdaq TradeTalks to discuss $XDNA, an ETF that seeks to capture the next generation of healthcare by investing in companies leading the CRISPR and gene editing revolution.